Shopping Cart 0
Cart Subtotal
AED 0

Rusnano Corp-Medical Equipment-Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Rusnano Corp (Rusnano) is an open joint stock company which develops Russian nanotechnology industry through co-investing in nanotechnology projects. It offers its service for a business entity and for non-commercial organization. The company's services include business structuring, co-financing, developing, control and investment of business entities. Its non-commercial organization services include management of nanotechnology centers, engineering companies, certification support, metrology, education, improving legislation, popularizing nanotechnology and infrastructure, among others. Rusnano's portfolio companies include Aquantia Corporation, Selecta Biosciences, Inc., Selecta RUS, Joule Unlimited, and OJSC Pharmsynthez, among others. It operates through its subsidiaries such as Rusnano US, Inc., Rusnano Israel Ltd., Rusnano Capital and Rusnanotech Forum Fund. The company is headquartered in Moscow, Russia.

Rusnano Corp-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Rusnano Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Rusnano Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6

Rusnano Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Rusnano Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 8

Rusnano Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

Rusnano Corp, Medical Equipment, Deal Details 11

Venture Financing 11

Bioptix Raises USD1.4 Million in Venture Financing 11

Miramar Labs Raises US$10 Million In Series D Financing 12

ReVision Optics Raises US$55 Million In Venture Financing 13

Neothetics Secures USD6.7 Million in Venture Funding 14

Regado Biosciences Raises US$51 Million In Series E Financing 15

CoDa Therapeutics Raises Additional US$20 Million In Series B Financing 17

Bioptix Diagnostics Raises US$9 Million In Series B Financing 18

Private Equity 19

Miramar Labs Raises USD9 Million in Financing 19

Acquisition 21

Rusnano Acquires 10% Stake In NTO IRE-Polus From IPG Photonics For US$20 Million 21

Rusnano Corp-Key Competitors 22

Key Employees 23

Locations And Subsidiaries 24

Head Office 24

Other Locations & Subsidiaries 24

Appendix 25

Methodology 25

About GlobalData 25

Contact Us 25

Disclaimer 25


List Of Figure

List of Figures

Rusnano Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Rusnano Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Rusnano Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Rusnano Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Rusnano Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Rusnano Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017 6

Rusnano Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Rusnano Corp, Medical Equipment, Deals by Market, 2011 to YTD 2017 8


List Of Table

List of Tables

Rusnano Corp, Medical Equipment, Key Facts 1

Rusnano Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Rusnano Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Rusnano Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6

Rusnano Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Rusnano Corp, Deals By Market, 2011 to YTD 2017 8

Rusnano Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

Bioptix Raises USD1.4 Million in Venture Financing 11

Miramar Labs Raises US$10 Million In Series D Financing 12

ReVision Optics Raises US$55 Million In Venture Financing 13

Neothetics Secures USD6.7 Million in Venture Funding 14

Regado Biosciences Raises US$51 Million In Series E Financing 15

CoDa Therapeutics Raises Additional US$20 Million In Series B Financing 17

Bioptix Diagnostics Raises US$9 Million In Series B Financing 18

Miramar Labs Raises USD9 Million in Financing 19

Rusnano Acquires 10% Stake In NTO IRE-Polus From IPG Photonics For US$20 Million 21

Rusnano Corp, Key Competitors 22

Rusnano Corp, Key Employees 23

Rusnano Corp, Subsidiaries 24

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Rusnano Corp (Rusnano) is an open joint stock company which develops Russian nanotechnology industry through co-investing in nanotechnology projects. It offers its service for a business entity and for non-commercial organization. The company's services include business structuring, co-financing, developing, control and investment of business entities. Its non-commercial organization services include management of nanotechnology centers, engineering companies, certification support, metrology, education, improving legislation, popularizing nanotechnology and infrastructure, among others. Rusnano's portfolio companies include Aquantia Corporation, Selecta Biosciences, Inc., Selecta RUS, Joule Unlimited, and OJSC Pharmsynthez, among others. It operates through its subsidiaries such as Rusnano US, Inc., Rusnano Israel Ltd., Rusnano Capital and Rusnanotech Forum Fund. The company is headquartered in Moscow, Russia.

Rusnano Corp-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Rusnano Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Rusnano Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6

Rusnano Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Rusnano Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 8

Rusnano Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

Rusnano Corp, Medical Equipment, Deal Details 11

Venture Financing 11

Bioptix Raises USD1.4 Million in Venture Financing 11

Miramar Labs Raises US$10 Million In Series D Financing 12

ReVision Optics Raises US$55 Million In Venture Financing 13

Neothetics Secures USD6.7 Million in Venture Funding 14

Regado Biosciences Raises US$51 Million In Series E Financing 15

CoDa Therapeutics Raises Additional US$20 Million In Series B Financing 17

Bioptix Diagnostics Raises US$9 Million In Series B Financing 18

Private Equity 19

Miramar Labs Raises USD9 Million in Financing 19

Acquisition 21

Rusnano Acquires 10% Stake In NTO IRE-Polus From IPG Photonics For US$20 Million 21

Rusnano Corp-Key Competitors 22

Key Employees 23

Locations And Subsidiaries 24

Head Office 24

Other Locations & Subsidiaries 24

Appendix 25

Methodology 25

About GlobalData 25

Contact Us 25

Disclaimer 25


List Of Figure

List of Figures

Rusnano Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Rusnano Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Rusnano Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Rusnano Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Rusnano Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Rusnano Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017 6

Rusnano Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Rusnano Corp, Medical Equipment, Deals by Market, 2011 to YTD 2017 8


List Of Table

List of Tables

Rusnano Corp, Medical Equipment, Key Facts 1

Rusnano Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Rusnano Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Rusnano Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6

Rusnano Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Rusnano Corp, Deals By Market, 2011 to YTD 2017 8

Rusnano Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

Bioptix Raises USD1.4 Million in Venture Financing 11

Miramar Labs Raises US$10 Million In Series D Financing 12

ReVision Optics Raises US$55 Million In Venture Financing 13

Neothetics Secures USD6.7 Million in Venture Funding 14

Regado Biosciences Raises US$51 Million In Series E Financing 15

CoDa Therapeutics Raises Additional US$20 Million In Series B Financing 17

Bioptix Diagnostics Raises US$9 Million In Series B Financing 18

Miramar Labs Raises USD9 Million in Financing 19

Rusnano Acquires 10% Stake In NTO IRE-Polus From IPG Photonics For US$20 Million 21

Rusnano Corp, Key Competitors 22

Rusnano Corp, Key Employees 23

Rusnano Corp, Subsidiaries 24

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com
chat_bubbleLet's Chat